DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Sargent DJ, Marsoni S, Thibodeau SN. et al.
Confirmation of deficient mismatch repair (dMMR) as a predictive marker for lack of benefit from 5-FU based chemotherapy in stage II and III colon cancer (CC): A pooled molecular reanalysis of randomized chemotherapy trials.
J Clin Oncol 2008; 26: 15S (Abstr 4008)-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.